Regulon

Regulon: R-3032

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
112.10124127Pr-7Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3071 ENSG00000123338 NCKAP1L P55160
241 ENSG00000132965 ALOX5AP P20292
55303 ENSG00000133574 GIMAP4 A0A090N7X0
272 ENSG00000133805 AMPD3 Q01432
283537 ENSG00000139508 SLC46A3 Q7Z3Q1
963 ENSG00000143119 CD53 P19397
6503 ENSG00000155926 SLA Q13239
3689 ENSG00000160255 ITGB2 D3DSM0
6850 ENSG00000165025 SYK P43405
3059 ENSG00000180353 HCLS1 P14317
5788 ENSG00000262418 PTPRC P08575

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
FOSTAMATINIB DISODIUMSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor40
FIBOFLAPON SODIUMALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30
R-343SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
AME-133VITGB2AntibodyINHIBITORIntegrin beta-2 inhibitor20
R-348SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
CERDULATINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK1 inhibitor20
EFALIZUMABITGALAntibodyINHIBITORIntegrin alpha-L/beta-2 (LFA-1) inhibitor40
HMPL-523SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor10
ENTOSPLETINIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
R-333SYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
GUSACITINIBSYKSmall moleculeINHIBITORJanus Kinase (JAK) inhibitor20
LIFITEGRASTITGALSmall moleculeANTAGONISTIntegrin alpha-L/beta-2 (LFA-1) antagonist40
MIVAVOTINIB CITRATESYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
VELIFLAPONALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30
FOSTAMATINIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor40
LANRAPLENIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
MIVAVOTINIBSYKSmall moleculeINHIBITORTyrosine-protein kinase SYK inhibitor20
FIBOFLAPONALOX5APSmall moleculeINHIBITOR5-lipoxygenase activating protein inhibitor30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3032

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-03609SSPOdown-regulatesFEVrepressesR-303252Drugs (18)
CMF-04227RBPJLdown-regulatesFEVrepressesR-303252Drugs (18)
CMF-04466MYH8down-regulatesFEVrepressesR-303253Drugs (18)
CMF-05638ITGB7down-regulatesFEVrepressesR-303252Drugs (18)
CMF-06077FGFR3down-regulatesFEVrepressesR-303251Drugs (18)
CMF-06113HTR5Adown-regulatesFEVrepressesR-303251Drugs (18)
CMF-07203NELL1down-regulatesFEVrepressesR-303252Drugs (18)
CMF-10008ALBdown-regulatesFEVrepressesR-303251Drugs (18)
CMF-11548PREX2down-regulatesFEVrepressesR-303251Drugs (18)
CMF-14620C1orf177down-regulatesFEVrepressesR-303251Drugs (18)
CMF-16748CPNE8down-regulatesFEVrepressesR-303251Drugs (18)
CMF-17304SYNJ2down-regulatesFEVrepressesR-303253Drugs (18)
CMF-17384TBC1D8down-regulatesFEVrepressesR-303251Drugs (18)
CMF-17530CNTNAP3down-regulatesFEVrepressesR-303251Drugs (18)
CMF-18332DNMBPdown-regulatesFEVrepressesR-303251Drugs (18)
CMF-19647RPSAP58down-regulatesFEVrepressesR-303254Drugs (18)
CMF-19693UGT2B4down-regulatesFEVrepressesR-303251Drugs (18)
CMF-20119TDRD9down-regulatesFEVrepressesR-303252Drugs (18)
CMF-21895PRAMEdown-regulatesFEVrepressesR-303253Drugs (18)
CMF-24327SMCHD1down-regulatesFEVrepressesR-303252Drugs (18)
CMF-24382PREX1down-regulatesFEVrepressesR-303251Drugs (18)
CMF-24949NLRP1down-regulatesFEVrepressesR-303253Drugs (18)
CMF-26584NAALADL1down-regulatesFEVrepressesR-303251Drugs (18)
CMF-27320CHD5down-regulatesFEVrepressesR-303254Drugs (18)
CMF-27507KRTAP20-2down-regulatesFEVrepressesR-303252Drugs (18)
CMF-27609ANKRD36down-regulatesFEVrepressesR-303252Drugs (18)
CMF-31048PNPLA7down-regulatesFEVrepressesR-303251Drugs (18)